Drug Discovery & Pharmaceuticals

RSS

Mayo Clinic and nference launch startup to develop drugs for rare diseases

Today, Mayo Clinic and nference launch a startup company for drug development that will be powered by clinical expertise and artificial intelligence (AI).

14 Jul 2017

Pharma, biotech and healthcare industries gender gap

The pharma and biotech industry continues to struggle to make progress with gender diversity. A recent Credit Suisse report shows that management diversity, as defined by percentage of women in senior management roles, has decreased globally from 18.9 percent in 2014 to 15.5 percent in 2016.

13 Jul 2017

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

13 Jul 2017

Salford scientists may have found simple way for designing new antibiotics

CANCER researchers in the UK may have stumbled across a solution to reverse antibiotic drug resistance and stop infections like MRSA.

12 Jul 2017

E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease

E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.

12 Jul 2017

Computational analysis of open-access data points to new ways of using drugs

A research team led by scientists at UC San Francisco has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.

12 Jul 2017

Erectile dysfunction drug may be used to coat stents in future heart surgeries

Coating stents with an erectile dysfunction drug may be the way forwards in treating stent patients, say researchers.

12 Jul 2017

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.

12 Jul 2017

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

A widely used screening tool deployed in the early phases of drug discovery to weed out undesirable compounds is wrong so often it can't be trusted on its own, according to scientists at the University of North Carolina at Chapel Hill.

11 Jul 2017

New DNA-based vaccine protects testes, sperm from Zika-related damage in mouse models

While the Zika virus is primarily transmitted by mosquitoes, research has shown that the disease can affect semen and sperm and can therefore be spread through sexual intercourse.

11 Jul 2017

First vaccine protecting against gonorrhea provides opportunity for vaccine development

A meningococcal group B vaccine has been found to offer protection against gonorrhea, report researchers. This is the first time a vaccine has protected against the STD and it could open up a new pathway for vaccine development.

11 Jul 2017

Medtech, biotech and pharmaceuticals in Australia

Australia is an acknowledged world leader in the medical technology, biotechnology and pharmaceutical (MTP) sector due to its vibrant ecosystem of start-ups and established companies and thriving research environment.

10 Jul 2017

UT Southwestern researchers develop novel chemical reaction that could accelerate drug development

Chemists have long sought to develop new reactions for the direct conversion of simple hydrocarbon building blocks into valuable materials such as pharmaceuticals in a way that dependably creates the same chemical bonds and orientations.

7 Jul 2017

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

Zoliflodacin, a novel first-in-class oral antibiotic and one of the only treatments in development to address the rapidly-growing threat of drug-resistant gonorrhea will enter pivotal trials, thanks to a new partnership between the not-for-profit Global Antibiotic Research and Development Partnership and Entasis Therapeutics.

7 Jul 2017

ActuRx and Insillico Medicine collaborate to prevent, treat age-related illnesses

Can big data and financial engineering cure Cancer, Alzheimer's, and other age-related illnesses? ActuRx and Insillico Medicine think so.

5 Jul 2017

Quantum dots may someday provide relief for eye infections

Quantum dots are transforming electronic displays on TVs and tablets. But now, one group reports in ACS Nano that these tiny structures may someday provide relief for eye infections resulting from contact lens wear, trauma or some types of surgeries.

5 Jul 2017

Scientists develop new class of pain medication without dangerous side effects

Scientists from Freie Universität Berlin and Charité - Universitätsmedizin Berlin at Campus Benjamin Franklin have developed a new class of pain medication.

4 Jul 2017

Study opens new range of therapeutic options for patients with atypical Rett syndrome

A translational, multicenter study carried out by research groups of the Bellvitge Biomedical Research Institute, San Juan de Dios Hospital, the University of Barcelona, Clinic Hospital, the University of Vic, Santa Creu i Sant Pau Hospital and the thematic area of Rare Diseases, has unveiled the potential of D-serine -- a dietary supplement -- to improve the neuronal function of a patient with a mutation of the glutamate receptors associated to atypical Rett syndrome with severe encephalopathy.

4 Jul 2017

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

The design of tailored peptide-polymer conjugates as drug-specific formulation additives offers access to next generation precision additives that can render problematic small organic drugs water-soluble and improve bioavailability.

30 Jun 2017

EPO blood doping has little effect on amateur cyclists’ road race performance

According to a new study published in The Lancet Haematology, recombinant human erythropoietin (rHuEPO), a performance augmenting drug has little effects on high-intensity laboratory cycling test among well-trained amateur cyclists; yet in the laboratory time trial test and endurance road-race up Mont Ventoux (France), the augmenting effects were typically undetectable.

30 Jun 2017

Drug Discovery & Pharmaceuticals

Mayo Clinic and nference launch startup to develop drugs for rare diseases

Pharma, biotech and healthcare industries gender gap

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

Salford scientists may have found simple way for designing new antibiotics

E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease

Computational analysis of open-access data points to new ways of using drugs

Erectile dysfunction drug may be used to coat stents in future heart surgeries

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

New DNA-based vaccine protects testes, sperm from Zika-related damage in mouse models

First vaccine protecting against gonorrhea provides opportunity for vaccine development

Medtech, biotech and pharmaceuticals in Australia

UT Southwestern researchers develop novel chemical reaction that could accelerate drug development

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

ActuRx and Insillico Medicine collaborate to prevent, treat age-related illnesses

Quantum dots may someday provide relief for eye infections

Scientists develop new class of pain medication without dangerous side effects

Study opens new range of therapeutic options for patients with atypical Rett syndrome

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

EPO blood doping has little effect on amateur cyclists’ road race performance

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News